Mirodenafil
Alternative Names: Aibishi; Bravonto; Mvix; SK-3530Latest Information Update: 10 Oct 2023
At a glance
- Originator SK Chemicals
- Developer In2Gen; SK Chemicals
- Class Antidementias; Antiparkinsonians; Anxiolytics; Erectile dysfunction therapies; Piperazines; Pyrimidinones; Small molecules; Sulfones; Vascular disorder therapies
- Mechanism of Action Type 5 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Erectile dysfunction
Most Recent Events
- 01 Oct 2023 Janssen Pharmaceuticals is now called Johnson & Johnson Innovative Medicine (Janssen Pharmaceuticals website, October 2023)
- 29 Jan 2015 SK Chemicals completes a phase I pharmacokinetic trial in Renal impaired patients in South Korea (NCT01232010)
- 05 Apr 2008 Pharmacokinetics data from a Phase-I trial in healthy volunteers presented at the 109th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT-2008)